Regression of tumors by IFN-α electroporation gene therapy and analysis of the responsible genes by cDNA array

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Gene Therapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301645PMID 11960315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant site

  2001cited by this paper
• IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs.

  2000cited by this paper
• IFN-α-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLs

  2000cited by this paper
• Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene.

  2000cited by this paper
• In Vivo Tumor Suppression by Adenovirus-Mediated Interferon alpha2b Gene Delivery

  1999cited by this paper
• High-efficiency gene transfer into skeletal muscle mediated by electric pulses.

  1999cited by this paper
• Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems

  1999cited by this paper
• Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

  1999cited by this paper
• Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

  1999cited by this paper
• Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation.

  1999cited by this paper
• Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

  1999cited by this paper
• Liposome-mediated gene transfer into human basal cell carcinoma

  1999cited by this paper
• Electropermeabilization of skeletal muscle enhances gene transfer in vivo

  1999cited by this paper
• Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.

  1998cited by this paper
• Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.

  1998cited by this paper
• Hyaluronan Fragments Synergize with Interferon-γ to Induce the C-X-C Chemokines Mig and Interferon-inducible Protein-10 in Mouse Macrophages*

  1998cited by this paper
• Gene transfer into muscle by electroporation in vivo.

  1998cited by this paper
• The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor.

  1998cited by this paper
• Differential viral induction of distinct interferon‐α genes by positive feedback through interferon regulatory factor‐7

  1998cited by this paper
• Nonviral Interferon α Gene Therapy Inhibits Growth of Established Tumors by Eliciting a Systemic Immune Response

  1998cited by this paper
• Nephritogenic T cells use granzyme C as a cytotoxic mediator

  1997cited by this paper
• Interferon-α gene therapy for cancer: retroviral transduction of fibroblasts and particle-mediated transfection of tumor cells are both effective strategies for gene delivery in murine tumor models

  1997cited by this paper
• A new immunocompetent murine model for oral cancer.

  1997cited by this paper
• Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

  1996cited by this paper
• In vivo gene electroinjection and expression in rat liver

  1996cited by this paper
• An overview of the interferon system: signal transduction and mechanisms of action.

  1996cited by this paper
• Gene therapy with an adeno-associated virus carrying an interferon gene results in tumor growth suppression and regression.

  1996cited by this paper
• Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro.

  1996cited by this paper
• High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation.

  1996cited by this paper
• Chemokine-leukocyte interactions. The voodoo that they do so well.

  1996cited by this paper
• Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.

  1995cited by this paper
• Antitumor activity of interleukin-1 alpha and cisplatin in a murine model system.

  1995cited by this paper
• Inhibition of growth of a murine squamous cell carcinoma by a cyclooxygenase inhibitor increases leukotriene B4 production.

  1995cited by this paper
• Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

  1995cited by this paper
• Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis.

  1995cited by this paper
• Antitumor Activity of Interleukin-1α and Cisplatin in a Murine Model System

  1995cited by this paper
• Mouse macrophage derived monocyte chemotactic protein-3: cDNA cloning and identification as MARC/FIC.

  1994cited by this paper
• Cytokine therapeutics: lessons from interferon alpha.

  1994cited by this paper
• Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.

  1993cited by this paper
• Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.

  1993cited by this paper
• Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.

  1991cited by this paper
• Implantation of genetically manipulated fibroblasts into mice as antitumor alpha-interferon therapy.

  1990cited by this paper
• Biology and clinical relevance of human natural killer cells.

  1990cited by this paper
• Implantation of Genetically Manipulated Fibroblasts into Mice as Antitumor α-Interferon Therapy

  1990cited by this paper
• Antitumor effects of interferon.

  1989cited by this paper
• The antitumor effects of interferon

  1986cited by this paper
• Antitumor effects of interferon in mice injected with interferon‐sensitive and interferon‐resistant friend leukemia cells. II. Role of host mechanisms

  1982cited by this paper

• Interferon α in cancer immunoediting: From elimination to escape

  2020cites this paper
• Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment

  2018cites this paper
• Thermal Considerations with Tissue Electroporation

  2018cites this paper
• Regulatory T cells and lymphocyte migration into intestinal tumors

  2016cites this paper
• CXCL9: evidence and contradictions for its role in tumor progression

  2016cites this paper
• Optimization of a plasma facilitated DNA delivery method.

  2015cites this paper
• 10.13 – Electroporation Therapy

  2014cites this paper
• Changing electrode orientation, but not pulse polarity, increases the efficacy of gene electrotransfer to tumors in vivo.

  2014cites this paper
• CD8+T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors

  2014cites this paper
• Imagerie in vivo du contrôle de l’inhibition génique et de l’électroporation d’ARN

  2012cites this paper
• Simultaneous induction of NKG2D and NKG2D ligand for promoting immune surveillance by IL-12 plus doxorubicin treatment

  2012cites this paper
• Interleukin‐30: A novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine‐induced liver injury

  2012cites this paper
• Gene Delivery Using Physical Methods

  2011cites this paper
• Gene Electrotransfer to Tumor

  2011cites this paper
• Irreversible Electroporation Therapy for the Treatment of Spontaneous Tumors in Cancer Patients

  2011cites this paper
• IL-12 and IL-27 Sequential Gene Therapy via Intramuscular Electroporation Delivery for Eliminating Distal Aggressive Tumors

  2010cites this paper
• Design of lipid and polymeric carriers for nucleic acid delivery

  2010cites this paper
• Eliminating Distal Aggressive Tumors Intramuscular Electroporation Delivery for IL-12 and IL-27 Sequential Gene Therapy via

  2010cites this paper
• Plasma Mediated Molecular Delivery

  2010cites this paper
• COTRASIF: conservation-aided transcription-factor-binding site finder

  2009cites this paper
• The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients

  2009cites this paper
• Delivery of DNA into tumors.

  2008cites this paper
• Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination.

  2008cites this paper
• Administering Plasmid DNA Encoding Tumor Vessel-anchored IFN-α for Localizing Gene Product Within or Into Tumors.

  2008cites this paper
• Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors.

  2008cites this paper
• DoxorubicinDirects theAccumulationof Interleukin-12^ Induced IFN; intoTumorsforEnhancingSTAT1^DependentAntitumorEffect

  2007cites this paper
• Doxorubicin Directs the Accumulation of Interleukin-12–Induced IFNγ into Tumors for Enhancing STAT1–Dependent Antitumor Effect

  2007cites this paper
• The Type I Interferon System With Emphasis on Its Role in Malignancies

  2007cites this paper
• Electroporation-mediated gene therapy

  2007influential citation
• In Vivo Electroporation for Gene Therapy

  2006cites this paper
• Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression.

  2006cites this paper
• The mechanism of exogenous B7.1‐enhanced IL‐12‐mediated complete regression of tumors by a single electroporation delivery

  2006cites this paper
• Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases.

  2006cites this paper
• Cytokines and chemokines as regulators of angiogenesis in health and disease.

  2006cites this paper
• Genetically modified IFN-alpha for gene therapy treatment of squamous cell carcinoma

  2006influential citation
• In vivo Gene electrotransfer: optimisation and mechanisms.

  2006cites this paper
• Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.

  2005cites this paper
• Transfert de gène in vivo: étude, régulation et application de l'électrotransfert

  2005cites this paper
• Cancer Gene Therapy

  2005cites this paper
• Electric pulse-mediated gene delivery to various animal tissues.

  2005cites this paper
• Anticancer Gene Therapy by in Vivo DNA Electrotransfer of MBD2 Antisense

  2005cites this paper
• Induction of IFN-regulated factors and antitumoral surveillance by transfected placebo plasmid DNA.

  2005cites this paper
• Electroporation for targeted gene transfer

  2005influential citation
• Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors

  2004cites this paper
• Cyclin L2, a Novel RNA Polymerase II-associated Cyclin, Is Involved in Pre-mRNA Splicing and Induces Apoptosis of Human Hepatocellular Carcinoma Cells*

  2004cites this paper
• Electroporation gene therapy: new developments in vivo and in vitro.

  2004cites this paper
• Functional and molecular characterization of interleukin‐2 transgenic Ewing tumor cells for in vivo immunotherapy

  2004cites this paper
• DNA electrotransfer: its principles and an updated review of its therapeutic applications

  2004cites this paper
• Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications

  2004cites this paper
• Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy

  2004cites this paper
• Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.

  2004cites this paper
• Combination of Optison TM with ultrasound and electroporation increases albumin and thrompoietin transgene expres sion whilst elongation factor promoter prolongs its dura tion

  2004cites this paper
• Expression of the Mig (CXCL9) gene in murine lung carcinoma cells generated angiogenesis-independent antitumor effects.

  2003cites this paper
• Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.

  2003cites this paper
• Type I interferon differential therapy for erythroleukemia: specificity of STAT activation.

  2003cites this paper
• Notch 1 Signaling Inhibits Growth of Human Hepatocellular Carcinoma through Induction of Cell Cycle Arrest and Apoptosis

  2003cites this paper
• Applications of Plasmid Electrotransfer

  2002cites this paper
• Current Awareness on Comparative and Functional Genomics

  2002cites this paper
• In vivo plasmid DNA electrotransfer.

  2002cites this paper